# Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism

> **NCT03284463** · PHASE2,PHASE3 · COMPLETED · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 306 (actual)

## Conditions studied

- Acute Stroke

## Interventions

- **DRUG:** Glibenclamide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03284463
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2022-08-28
- **Final completion:** 2023-05-28
- **Target enrollment:** 306 (ACTUAL)
- **Last updated:** 2023-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03284463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03284463, "Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03284463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*